Drug recall D-1343-2022
Product
Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, 21202 NDC: 68180-658-06
Reason for recall
CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.
Lots and codes
Lot #A200170, exp. date December 2023
Recall details
- Recalling firm
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Quantity
- 7,872/30 count bottles
- Distribution
- Product was distributed nationwide.
- Type
- Voluntary: Firm initiated
- Recall initiated
- July 28, 2022
- Terminated
- October 5, 2023
Related products
- Rifampin – drug information
- NDC 68180-658 rifampin · Rifampin 150 mg/1 · Lupin Pharmaceuticals, Inc.
- NDC 68180-659 rifampin · Rifampin 300 mg/1 · Lupin Pharmaceuticals, Inc.